Karyopharm logo
Karyopharm logo

Karyopharm

karyopharm.com
karyopharm.com · HQ: Newton, United States · Grant 2018 · 501-1000 employees
HQ: Newton, United States · Grant 2018 · 501-1000 employees
Actively hiring
Biotechnology
Health Care
Prescription Drugs
As featured in
The Globe And Mail
Street Insider
Morningstar
SeekingAlpha
Fierce Pharma
View 1 job
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Jobs
Financials

Overview

Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer.

News

Press release The Globe and Mail 1 month ago
Karyopharm Faces Liquidity Crisis Under Forbearance Agreement
Detailed price information for Karyopharm Therapeut (KPTI-Q) from The Globe and Mail including charting and trades.
Read more
Report
Press release streetinsider.com 2 months ago
Karyopharm Submits Supplemental New Drug Application to the FDA for XPOVIO (selinexor) Plus Ruxolitinib for Patients with Myelofibrosis Read more
Report
Press release morningstar.com 2 months ago
Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission Read more
Report
Press release morningstar.com 3 months ago
Karyopharm Plans to Submit sNDA for Selinexor Plus Ruxolitinib in Myelofibrosis Under Accelerated Approval Pathway Read more
Report
News seekingalpha.com 7 months ago
Karyopharm to seek label expansion for Xpovio in myelofibrosis after late-stage trial win Read more
Report
News fiercepharma.com 3 years ago
Karyopharm cuts 20% of workforce as sales of blood cancer drug Xpovio stagnate Read more
Report
News fiercepharma.com 4 years ago
FDA says no, thank you to Xpovio's cancer expansion bid, prompting Karyopharm to run new study Read more
Report
Podcast 5 years ago
Sample Podcast #2
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Vestibulum tortor quam, feugiat vitae, ultricies eget, tempor...
Read more
Report
Podcast 6 years ago
Sample Podcast
Learn about our offerings at KaryoPharm with our latest KaryoCast!
Read more
Report

Salary insights

Compensation ranges based on this company's open jobs
Median
$220k
Typical range
$220k
Open positions
1
1 Jobs
Junior 100%
Level Jobs Median Typical range
Junior 1 $220k $220k
Highest paying role Medical Science Liaison (MSL) - Southwest $220k
Normalized to USD per year

People

Stuart Poulton
Executive Officer
SEC Form D
Michael Mano
Executive Officer
SEC Form D
Reshma Rangwala
Executive Officer
SEC Form D
Richard Paulson
Executive Officer, Director
SEC Form D
Stephen Mitchener
Executive Officer
SEC Form D
Michael Mason
Executive Officer
SEC Form D
Sohanya Cheng
Executive Officer
SEC Form D
Peter Honig
Director
SEC Form D
Barry Greene
Director
SEC Form D
Deepika Pakianathan
Director
SEC Form D
Chen Schor
Director
SEC Form D
Mansoor Mirza
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Growth

Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
100% ▲

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Newton United States
HQ
500-1000 est. staff

Jobs

$180k – $220k per year · In office · 1+ year exp · PhD · United States
HIPAA
Apply

Financials

Total raised
$2.2M
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2018 $2M Details
Grant 2016 $225k Details